We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics


Serosep Ltd. is one of Ireland’s leading diagnostics specialists and an innovative, specialist partner of choice for ... read more Featured Products: More products

Download Mobile App

Serosep Exhibits EntericBio System for Testing, Detecting and Identifying GI Pathogens at MEDICA 2022

By LabMedica International staff writers
Posted on 14 Nov 2022
Print article
Image: The EntericBio system is revolutionizing molecular Entericbio testing (Photo courtesy of Serosep)
Image: The EntericBio system is revolutionizing molecular Entericbio testing (Photo courtesy of Serosep)

Serosep Ltd. (Limerick Ireland) is exhibiting its unique system that is revolutionizing molecular testing of gastrointestinal (GI) pathogens at the MEDICA 2022 International Trade Fair being held on November 14-17 in Düsseldorf, Germany. MEDICA is the world's largest medical trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics and pharmaceuticals.

At MEDICA 2022, Serosep is exhibiting its EntericBio system which is the market leader in GI realtime PCR testing in the UK/Ireland and provides medium/high throughput labs with a rapid, reliable and easy to use solution for their enteric pathogen testing needs. The EntericBio system is unique as it is capable of detecting target DNA and RNA directly from stool specimens, circumventing the requirement for commercial nucleic acid extraction purification and minimizes hands on time for the laboratory personnel. The EntericBio system provides a complete and flexible modular menu for testing, detecting and identifying GI pathogens including bacteria, parasites, CPE and viruses within the same work-flow and platform with a result for up to 46 specimens per run in les than three hours and results for consecutive runs each hour.

Serosep is also highlighting its comprehensive range of pre-filled Histopot specimen containers for use in histology and pathology laboratories. These biopsy sample containers are manufactured to the highest standard, using quality state of the art production techniques, in a certified manufacturing facility. The HistoPot ensures the safety during patients’ biopsy sample fixation, which is the single most important stage in the histopathology process. The HistoPot is regarded as one of the benchmarks for the fixation and transportation of millions of critical histological samples worldwide.

Related Links:
Serosep Ltd.

Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rickettsia Conorii Assay

Print article


Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more


view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more


view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more


view channel
Image: The tool can improve precision oncology by accurately predicting molecular subtypes and therapy responses (Photo courtesy of Shutterstock)

Computational Tool Integrates Transcriptomic Data for Improved Breast Cancer Diagnosis and Treatment

Breast cancer is the most commonly diagnosed cancer globally, presenting in various subtypes that require precise identification for effective, personalized treatment. Traditionally, cancer subtyping has... Read more


view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.